1. Altered astrocytic function in experimental neuroinflammation and multiple sclerosis
- Author
-
João José Cerqueira, Nuno Sousa, Fernanda Marques, Sofia Pereira das Neves, and João Carlos Sousa
- Subjects
0301 basic medicine ,Encephalomyelitis, Autoimmune, Experimental ,Multiple Sclerosis ,Central nervous system ,Inflammation ,Biology ,Glial scar ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,medicine ,Animals ,Humans ,Neuroinflammation ,Microglia ,Multiple sclerosis ,Experimental autoimmune encephalomyelitis ,Neurodegeneration ,medicine.disease ,3. Good health ,Disease Models, Animal ,030104 developmental biology ,medicine.anatomical_structure ,Neurology ,Astrocytes ,Neuroinflammatory Diseases ,medicine.symptom ,Neuroscience ,030217 neurology & neurosurgery - Abstract
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that affects about 2.5 million people worldwide. In MS, the patients' immune system starts to attack the myelin sheath, leading to demyelination, neurodegeneration, and, ultimately, loss of vital neurological functions such as walking. There is currently no cure for MS and the available treatments only slow the initial phases of the disease. The later-disease mechanisms are poorly understood and do not directly correlate with the activity of immune system cells, the main target of the available treatments. Instead, evidence suggests that disease progression and disability are better correlated with the maintenance of a persistent low-grade inflammation inside the CNS, driven by local glial cells, like astrocytes and microglia. Depending on the context, astrocytes can (a) exacerbate inflammation or (b) promote immunosuppression and tissue repair. In this review, we will address the present knowledge that exists regarding the role of astrocytes in MS and experimental animal models of the disease.
- Published
- 2020